INTENT Biologics Receives FDA Breakthrough Therapy Designation for PEP BiologicTM for its Phase 3 Ready Flagship Indication

ROCHESTER, Minn.--(BUSINESS WIRE)--INTENT Biologics Receives FDA Breakthrough Therapy Designation for PEP BiologicTM for its Phase 3 Ready Flagship Indication